Happy to be part of the group.

🦠COVID UPDATE LIVERPOOL🦠 We are now in a very difficult position. Our current risk level is high. Latest 7 day rate up to 24th September is approx 252/100,000, and positivity rate is 12.8%. Doubling rate is 8-9 days. #covid19 /1

The fight against #HIV can be challenging - here how Hannah Kinvig at the Inst of Systems, Molecular & Integrative Biology University of Liverpool is developing innovative methods to improve understanding of drug interactions and to support novel formulations #WorldAIDSDay news.liverpool.ac.uk/2020/12/01/bec…

As we approach #IWD2021, VirTUAL Consortium celebrates the skills, energy and creativity of our female team members who #ChooseToChallenge many stereotypes. Maiara Camotti Montanha, working with Marco Siccardi is building PBPK models to understand drug-drug interactions in HIV and TB

#IWD2021 VirTUAL Consortium celebrates the team members who work tirelessly behind the scenes to ensure excellence and success. Yvonne Kamara has supported our team on many occasions, always remaining calm, optimistic and organised.

After five years we are pleased to set up the dates for the second edition of #SISLif. Please be advised that, due to the Novel Coronavirus (COVID-2019) situation, this year (2021) the edition will be 100% online 💻🖥. 🔜 The registration will open soon, stay tuned.

Don't miss out the 2nd International Symposium on Drug Delivery Systems: innovation, technology and pharmacometrics 13-16 SEPTEMBER, 2021 iisislif.ciente.live

We are delighted to publish our #PBPK model for dose escalation of ritonavir-boosted atazanavir to overcome the interaction with rifampicin. The clinical trial is underway: initial results presented at #EDCTPforum this week support model accuracy. link.springer.com/article/10.100…

Congratulations Shakir Atoyebi - it's great to see these data 'out' to inform how LAI might be used in pregnancy. Also, fantastic achievement in the first year of your PhD! Maiara Camotti Montanha Hannah Kinvig Marco Siccardi Inst of Systems, Molecular & Integrative Biology Colin Pillai Adeniyi Olagunju

Happy to be participating of #CROI2022 and presenting in today's poster session how PBPK models can help dose selection in pediatric population. VirTUAL Consortium Catriona Waitt